§ The providers
Who sells what — and who to trust.

An independent overview of the compounded-GLP-1 telehealth market and the providers we cover — market size, what the FDA changed, and an honest read on each.

View the provider overviewOverview & reviews
§ Learn
The educational layer, in progress.

Primers for newcomers and deep dives for the curious. The foundation articles are published; more are in the pipeline.

View all Learn articles
503A + 503B · Ocala, FL & Dyersburg, TN

Wells Pharmacy Network: 503A + 503B compounder profile

A PCAB-accredited dual operator — a 503A pharmacy in Ocala, FL plus a 503B outsourcing facility in Dyersburg, TN — strong in HRT/BHRT, weight, and peptides. Not the same company as Wells Pharma of Houston.

Editorial independence

This profile is editorial. PeptideWellness has no commercial relationship with this pharmacy; coverage and assessment are never for sale.

Wells Pharmacy Network runs both a patient-specific 503A pharmacy and an FDA-registered 503B outsourcing facility. One disambiguation up front: this is Wells Pharmacy Network, LLC — a different company from Wells Pharma of Houston, LLC (a separate Houston hospital-injectables 503B).

Facility & accreditation

The legal entity is Wells Pharmacy Network, LLC. It operates a 503A pharmacy in Ocala, FL and a 503B outsourcing facility in Dyersburg, TN — the latter appears on the FDA 503B list as “Wells Pharmacy, Inc.,” Dyersburg, TN (initial registration 2016-06-07) [1]. We independently confirmed PCAB accreditation for the Ocala 503A in ACHC’s own directory (Wells Pharmacy Network, LLC, Ocala, FL) [2]. The site also displays PCAB, PCCA, and Alliance for Pharmacy Compounding logos, and says it ships nationwide [3].

What they compound

On-audience: wellness/anti-aging, weight management, sexual wellness, HRT/BHRT (including bioidentical hormone pellets), thyroid/adrenal, and longevity, plus peptides such as sermorelin [3]. Its public “trending” mix leans HRT/sermorelin/NAD+/thyroid; compounded GLP-1 is offered under weight management.

Regulatory record

We found no FDA warning letter for Wells Pharmacy Network in public sources. The Dyersburg 503B facility carries an FDA-list footnote indicating a prior inspection resulting in a 483/action, with its most recent inspection logged 2026-04-09 [1]; we did not retrieve a specific dated document beyond that flag, so we don’t assert specifics. A Form 483 documents inspection observations, not a final finding. Dated to our review; status can change.

The read

A well-established dual 503A/503B operator with PCAB accreditation independently confirmed on the 503A side — a good “how a dual-status compounder works” example, strong in HRT/BHRT and peptides. Watch the Dyersburg 503B’s inspection history, and don’t confuse it with the unrelated Wells Pharma of Houston.

References

  1. FDA — Registered Outsourcing Facilities (503B) list (“Wells Pharmacy, Inc.,” Dyersburg, TN). https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities (accessed 2026-07-01)
  2. ACHC / PCAB accredited-organization directory (Wells Pharmacy Network, LLC, Ocala, FL). https://organization.achc.org/ (accessed 2026-07-01)
  3. Wells Pharmacy Network — official site. https://wellsrx.com/ (accessed 2026-07-01)
§ The Daily

The peptide brief, delivered.

A 5-minute daily digest on peptide therapy news, provider updates, and regulatory changes.

Find your peptide Take 60-sec quiz